At the Thyroid Cancer Center of Dana-Farber Brigham Cancer Center, our mission is to combine world-class patient care with leading-edge research – to provide highly effective, personalized treatment options for patients with thyroid cancer and nodular disease.
As part of Dana-Farber Brigham Cancer Center's Head and Neck Cancer Treatment Center, the Thyroid Cancer Center is staffed by a multidisciplinary team of leading medical oncologists, surgical oncologists, endocrinologists, endocrine surgeons, cytopathologists, radiologists, and other specialists dedicated to producing the best possible results for our patients.
The Thyroid Cancer Center brings together a nationally-recognized team of experienced specialists who are advancing our understanding of thyroid cancer and nodular disease – and are developing new approaches for diagnosis and treatment.
Dedicated to advancing the way thyroid cancer is diagnosed and treated, the Center's renowned clinical team provides timely, compassionate, and comprehensive multidisciplinary care across the full spectrum of cancer services.
Learn more about thyroid cancer diagnosis and treatment.
Starting with your initial consultation, your team will work with you to create a comprehensive treatment plan tailored to your type of cancer, your lifestyle, and your personal needs. We develop personalized approaches for each patient – from assessment of nodules and surgical treatment to targeted therapy for metastatic thyroid cancer – in order to reach the best outcome possible.
Care and Research Inform One Another
One of our Center's most important goals is to develop better ways to treat thyroid cancer. Our specialists meet regularly to discuss new developments in clinical and basic research. The close relationships between Dana-Farber Brigham Cancer Center's expert clinicians and researchers through its Thyroid Cancer 360 Program help us to translate the latest research findings into new, effective treatment approaches.
Read our Insight blog's informative story, Why Are Thyroid Cancer Cases on the Rise?